Free Trial
NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

$0.07
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$0.05
$0.07
50-Day Range
$0.04
$0.18
52-Week Range
$0.03
$10.05
Volume
16,284 shs
Average Volume
70,099 shs
Market Capitalization
$386,590.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.88
MOTS stock logo

About Motus GI Stock (NASDAQ:MOTS)

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

MOTS Stock Price History

MOTS Stock News Headlines

Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.
Motus GI Holdings Inc
Why Is Motus GI (MOTS) Stock Down 37% Today?
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.
Motus GI Holdings, Inc. (MOTS)
Motus GI Holdings Inc.
See More Headlines
Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2024
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:MOTS
Employees
15
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.88
High Stock Price Target
$37.50
Low Stock Price Target
$20.25
Potential Upside/Downside
+42,997.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-12,870,000.00
Net Margins
-3,239.75%
Pretax Margin
-3,239.75%

Debt

Sales & Book Value

Annual Sales
$320,000.00
Book Value
$1.74 per share

Miscellaneous

Free Float
5,749,000
Market Cap
$386,590.00
Optionable
Not Optionable
Beta
1.81
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives


MOTS Stock Analysis - Frequently Asked Questions

How have MOTS shares performed this year?

Motus GI's stock was trading at $1.2750 at the start of the year. Since then, MOTS shares have decreased by 94.7% and is now trading at $0.0670.
View the best growth stocks for 2024 here
.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) posted its earnings results on Tuesday, May, 14th. The company reported ($0.88) EPS for the quarter. The firm earned $0.06 million during the quarter. Motus GI had a negative trailing twelve-month return on equity of 1,731.08% and a negative net margin of 3,239.75%.

When did Motus GI's stock split?

Motus GI shares reverse split on the morning of Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Motus GI IPO?

Motus GI (MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

How do I buy shares of Motus GI?

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Motus GI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Matinas BioPharma (MTNB), Allena Pharmaceuticals (ALNA), VYNE Therapeutics (VYNE), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD), Sorrento Therapeutics (SRNE) and Pfizer (PFE).

This page (NASDAQ:MOTS) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners